Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin use in critically ill patients: PK/PD, tolerance profile and resistance risk
2015-003708-22Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistin in multidrug-resistant Gram-negative infection, sepsis and Bacteremia, sponsored by Erasmus Hospital. Started Sep 2015; status: completed.
02
Drugs
colistin
03
Conditions
multidrug-resistant Gram-negative infectionsepsisBacteremia
Beyond the preview
Go deeper on 2015-003708-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003708-22.